SPRINGFIELD, NJ, and WAYNE, PA — Hudson and Argosy Healthcare Partners portfolio company has announced the appointment of Werner Maas as Chief Executive Officer. Maas, a seasoned leader in the life science tools industry, is renowned for his ability to drive growth and innovation.
Maas brings a wealth of experience from his previous role as President of the Global Liquid Handling business at Mettler Toledo, where he oversaw the Rainin and Biotix units. Before that, he led the Magnetic Resonance division of Bruker Biospin Group, advancing their scientific instruments and diagnostic solutions.
Expressing his enthusiasm for the new role, Maas stated, “Hudson is known for its innovative solutions and deep product portfolio, providing scientists the means to reach higher productivity and reproducible results, and I am excited to join the company at this unique moment in its growth. I look forward to working with the entire team to build on the company’s strong foundation and help accelerate its success across all markets.”
Dr. Ian Shuttler, Executive Chairman, welcomed Maas, saying, “We are excited to welcome Werner to Hudson and have him guide the organization through its next stage of growth. Hudson brought together three companies with the acquisitions of Hudson Robotics, Art Robbins Instruments, and Tomtec, and we look forward to Werner uniting the organization and driving customer centricity, innovation, and growth in the years ahead.”
As part of the leadership transition, Andrew Witschi will assume the role of President of Hudson Robotics and Head of Technology. This change underscores Hudson’s commitment to delivering advanced automation solutions, ensuring high quality and reliability in the life sciences sector. Under Maas’s leadership, Hudson aims to build on its strong foundation and expand its market presence through innovation and customer-focused strategies.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.